35628290|t|Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization.
35628290|a|Inflammatory responses by the innate and adaptive immune systems protect against infections and are essential to health and survival. Many diseases including atherosclerosis, osteoarthritis, rheumatoid arthritis, psoriasis, and obesity involve persistent chronic inflammation. Currently available anti-inflammatory agents, including non-steroidal anti-inflammatory drugs, steroids, and biologics, are often unsafe for chronic use due to adverse effects. The development of effective non-toxic anti-inflammatory agents for chronic use remains an important research arena. We previously reported that oral administration of Oxy210, a semi-synthetic oxysterol, ameliorates non-alcoholic steatohepatitis (NASH) induced by a high-fat diet in APOE*3-Leiden.CETP humanized mouse model of NASH and inhibits expression of hepatic and circulating levels of inflammatory cytokines. Here, we show that Oxy210 also inhibits diet-induced white adipose tissue inflammation in APOE*3-Leiden.CETP mice, evidenced by the inhibition of adipose tissue expression of IL-6, MCP-1, and CD68 macrophage marker. Oxy210 and related analogs exhibit anti-inflammatory effects in macrophages treated with lipopolysaccharide in vitro, mediated through inhibition of toll-like receptor 4 (TLR4), TLR2, and AP-1 signaling, independent of cyclooxygenase enzymes or steroid receptors. The anti-inflammatory effects of Oxy210 are correlated with the inhibition of macrophage polarization. We propose that Oxy210 and its structural analogs may be attractive candidates for future therapeutic development for targeting inflammatory diseases.
35628290	0	6	Oxy210	Chemical	-
35628290	25	34	Oxysterol	Chemical	MESH:D000072376
35628290	48	60	Inflammatory	Disease	MESH:D007249
35628290	102	128	Toll-like Receptor (TLR) 4	Gene	21898
35628290	133	137	TLR2	Gene	24088
35628290	191	203	Inflammatory	Disease	MESH:D007249
35628290	272	282	infections	Disease	MESH:D007239
35628290	349	364	atherosclerosis	Disease	MESH:D050197
35628290	366	380	osteoarthritis	Disease	MESH:D010003
35628290	382	402	rheumatoid arthritis	Disease	MESH:D001172
35628290	404	413	psoriasis	Disease	MESH:D011565
35628290	419	426	obesity	Disease	MESH:D009765
35628290	446	466	chronic inflammation	Disease	MESH:D007249
35628290	493	505	inflammatory	Disease	MESH:D007249
35628290	563	571	steroids	Chemical	MESH:D013256
35628290	689	701	inflammatory	Disease	MESH:D007249
35628290	813	819	Oxy210	Chemical	-
35628290	838	847	oxysterol	Chemical	MESH:D000072376
35628290	861	890	non-alcoholic steatohepatitis	Disease	MESH:D005235
35628290	892	896	NASH	Disease	MESH:D005235
35628290	957	962	mouse	Species	10090
35628290	972	976	NASH	Disease	MESH:D005235
35628290	1081	1087	Oxy210	Chemical	-
35628290	1121	1148	adipose tissue inflammation	Disease	MESH:D007249
35628290	1171	1175	mice	Species	10090
35628290	1237	1241	IL-6	Gene	16193
35628290	1243	1248	MCP-1	Gene	17224
35628290	1254	1258	CD68	Gene	12514
35628290	1278	1284	Oxy210	Chemical	-
35628290	1318	1330	inflammatory	Disease	MESH:D007249
35628290	1367	1385	lipopolysaccharide	Chemical	MESH:D008070
35628290	1427	1447	toll-like receptor 4	Gene	21898
35628290	1449	1453	TLR4	Gene	21898
35628290	1456	1460	TLR2	Gene	24088
35628290	1466	1470	AP-1	Gene	16476
35628290	1551	1563	inflammatory	Disease	MESH:D007249
35628290	1575	1581	Oxy210	Chemical	-
35628290	1661	1667	Oxy210	Chemical	-
35628290	1773	1794	inflammatory diseases	Disease	MESH:D007249
35628290	Negative_Correlation	MESH:D013256	MESH:D007249
35628290	Association	MESH:D007249	24088
35628290	Association	MESH:D007249	21898
35628290	Negative_Correlation	MESH:D000072376	MESH:D007249

